Aramark (ARMK) Director Reports 79.515 Shares via Dividend Equivalents

Rhea-AI Filing Summary

Bridgette P. Heller, a director of Aramark (ARMK), reported a non‑derivative acquisition on 08/20/2025. The Form 4 shows 79.515 shares acquired at $0, recorded as dividend equivalent rights that accrued on deferred stock units and vest on the same schedule as the underlying awards. Following the reported transaction, the filing lists 30,416.4 shares beneficially owned in a direct form. The filing was submitted by one reporting person and signed by an attorney‑in‑fact on 08/21/2025. The report includes the reporter's address at Aramark's Philadelphia office.

Insights

Financial Analyst

TL;DR: Director received dividend‑linked equity of modest size; no cash purchase or exercise disclosed, so near‑term dilution and cash impact are minimal.

The Form 4 records the automatic accrual and vesting of 79.515 dividend equivalent shares tied to deferred stock units rather than a market purchase. Because the transaction is classified as acquisition at $0, it reflects compensation or dividend settlement mechanics instead of open‑market buying. The post‑transaction beneficial ownership of 30,416.4 shares provides context for the director's stake, but the reported increment is immaterial relative to typical institutional holdings and does not signal a change in governance control or significant financial commitment.

Corporate Governance Expert

TL;DR: Routine equity compensation event for a director; governance implications are minimal and discloseable under Section 16.

This filing documents dividend equivalent rights vesting on deferred stock units held by the director, a standard form of director compensation. The item is appropriately reported on Form 4 with transaction date 08/20/2025 and signature by an attorney‑in‑fact. There is no indication of related-party transfers, option exercises, or other arrangements that would raise governance or compliance concerns.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Heller Bridgette P

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2025		A		79.515(1)	A	$0	30,416.4	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did ARMK director Bridgette P. Heller report on Form 4?

The director reported acquiring 79.515 shares on 08/20/2025, recorded as dividend equivalent rights tied to deferred stock units.

Why is the price listed as $0 on the ARMK Form 4?

The filing states the shares represent dividend equivalent rights that accrued on deferred stock units, so the acquisition was not a market purchase and is listed at $0.

How many ARMK shares does Bridgette P. Heller beneficially own after the reported transaction?

The Form 4 shows 30,416.4 shares beneficially owned following the reported transaction.

When was the ARMK Form 4 signed and who signed it?

The filing was signed by an attorney‑in‑fact, Ryan S. Spengler, on 08/21/2025.

What is the nature of the equity awarded to the ARMK director in this filing?

The equity consists of dividend equivalent rights that vest on the same schedule as the underlying deferred stock unit awards.